Dr Schilling is a Partner and member of the Global Operations team at TPG Capital. At TPG, Dr Schilling has responsibility for leading the Operations efforts for and supporting the investment activity in the Healthcare Portfolio Companies. Dr Schilling also chairs the Board of Nutrition Science Initiative, a not-for-profit focused on nutrition research. Prior to joining TPG, Dr Schilling was a Corporate Officer and Vice President of Sales and Marketing for the US Pharmaceutical business at Abbott Laboratories. While at Abbott, he had Profit and Loss responsibility for multiple franchises, including Primary Care, Endocrinology, Oncology, Renal, Virology, and Mature Products, along with contracting for US Managed Care and Trade. Before joining Abbott, Dr Schilling was a partner at McKinsey and Company, where he served clients across the healthcare landscape—focusing on growth, mergers and acquisitions, commercialization of new products and services, and corporate strategy. Dr Schilling received his Bachelor’s degree with Distinction in Biomedical and Electrical Engineering from Duke University, his Master’s degree in Biomedical Engineering from the Johns Hopkins University, where he was a Bozzelli Scholar, and his MD with Honors from the University of Chicago. Following medical school, Dr Schilling conducted his residency training in General Surgery at the Johns Hopkins Hospital and School of Medicine.

nutrition research